For San Diego researchers and the wider immunotherapy community, the atlas functions as a practical roadmap. It does not ...

In this roundtable, our panel of scientists will highlight the adoption of biomarker strategies that can create efficiency in your clinical cell therapy development efforts. Specific areas of focus ...

A new predictive framework reprograms T cells to sustain immune memory while preserving their ability to fight cancer and infections.

Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial We analyzed ...

Using the fast metabolic glycan labeling (fMGL) technique, AMS-ManNAz-P was incorporated into the terminal sialic acids of various cell-surface glycans on γδ T cells. The modified γδ T cells were then ...

Adoptive cell therapies (ACT) have become a transformative force in cancer immunology, offering powerful platforms for targeting both hematological and ...

Scientists have discovered key genetic factors that determine whether a T cell acts as a powerful disease fighter or enters an ineffective, exhausted state.

Immatics N.V., a clinical-stage biopharmaceutical company, announced that it will present data on its lead cell therapy candidate, IMA203 TCR T-cell therapy targeting PRAME, at the upcoming 2025 ASCO ...

Add Yahoo as a preferred source to see more of our stories on Google. Kim and Khloé Kardashian had stem cell therapy in Mexico overseen by Dr. Adeel Khan. (Photo illustration: Yahoo News; photos: Kim ...